Rankings
▼
Calendar
FBLG FY 2022 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$5M
EPS (Diluted)
$-0.16
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$265,000
Balance Sheet
Total Assets
$5M
Total Liabilities
$9M
Stockholders' Equity
-$4M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$4M
-$2M
-183.1%
Net Income
-$5M
-$2M
-223.7%
← FY 2021
All Quarters
Q1 2022 →